#Clinical Trials

Treeline Biosciences Raises $200M, Initiates Clinical Trials

The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.

Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline

Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.

Comphya Secures €8M Series A for ED Neurostimulation

CNBC Disruptor 50 on Formation Bio to Redefine Drug Development

Neuralink Secures Massive $650M Series E Funding

Vivodyne Secures $40 Million to Revolutionize Drug Discovery

Veltist Secures €160,000 in Funding for Innovative Surgical Patch

MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry

Zetaris Launches AI Clinical Assistant for Improved Healthcare Outcomes